NCT01467414View on ClinicalTrials.gov

A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 2 Diabetes

PHASE1TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin degludec

Injected s.c. (under the skin) once daily for 6 days

Trial Locations (1)

41460

Neuss

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY